Pancreatic Cancer Research

ResearcherTokushima UniversityNo recent work listed

Koji Sugimoto

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper

Papers 2

  1. Valproic acid enhances the anti-tumor effect of pegylated interferon-α towards pancreatic cancer cell lines. Co-author PMID 24982347↗
  2. Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells. Co-author DOI 10.1007/s10147-011-0246-y↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuichi Iwahashi · 2 shared papers, 2011–2014 · strength 0.07
  2. Tetsuya Ikemoto · 2 shared papers, 2011–2014 · strength 0.07
  3. Mitsuo Shimada · 2 shared papers, 2011–2014 · strength 0.07
  4. Tohru Utsunomiya · 1 shared paper, 2011 · strength 0.03
  5. Yu Saito · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.